
Rafael Romero-Becerra
- Postdoc researcher; PhD
Interested in drug combination therapies and biomarker identification. Experienced in in vivo data analysis, statistical modeling, and bioinformatics. Expertise in mixed-effects modeling, R package and Shiny app development, and omics data analysis (phospho/proteomics, transcriptomics, scRNA-Seq). Background in biochemistry, molecular biomedicine, and biostatistics.
Publications 2025
Absence of MCJ/DnaJC15 promotes brown adipose tissue thermogenesis
Nat Commun, 16 (1), 229
DOI 10.1038/s41467-024-54353-4, PubMed 39805849
Publications 2024
Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis
EMBO Rep, 25 (6), 2635-2661
DOI 10.1038/s44319-024-00149-y, PubMed 38730210
Publications 2023
p38γ/δ activation alters cardiac electrical activity and predisposes to ventricular arrhythmia
Nat Cardiovasc Res, 2 (12), 1204-1220
DOI 10.1038/s44161-023-00368-x, PubMed 39196141
Publications 2022
Targeting ERK3/MK5 complex for treatment of obesity and diabetes
Biochem Biophys Res Commun, 612, 119-125
DOI 10.1016/j.bbrc.2022.04.070, PubMed 35523049
MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation
Elife, 11
DOI 10.7554/eLife.75250, PubMed 35971771
Publications 2020
p38 MAPK Pathway in the Heart: New Insights in Health and Disease
Int J Mol Sci, 21 (19)
DOI 10.3390/ijms21197412, PubMed 33049962
Publications 2019
p38γ is essential for cell cycle progression and liver tumorigenesis
Nature, 568 (7753), 557-560
DOI 10.1038/s41586-019-1112-8, PubMed 30971822